Όλο το DSpace

Πλοήγηση ανά Θέμα "antifibrotic activity"

Αποτελέσματα 1-2 από 2

    • Efficacy and safety of nintedanib in a greek multicentre idiopathic pulmonary fibrosis registry: A retrospective, observational, cohort study 

      Antoniou K., Markopoulou K., Tzouvelekis A., Trachalaki A., Vasarmidi E., Organtzis J., Tzilas V., Bouros E., Kounti G., Rampiadou C., Kotoulas S.-C., Bardaka F., Bibaki E., Fouka E., Meletis G., Tryfon S., Daniil Z., Papakosta D., Bouros D. (2020)
      Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety of ...

    • Mechanisms for cardiorenal protection of sglt-2 inhibitors 

      Georgianos P.I., Vaios V., Dounousi E., Salmas M., Eleftheriadis T., Liakopoulos V. (2021)
      Despite optimal treatment of diabetic kidney disease (DKD) with adequate blood pressure control and agents blocking the renin-angiotensin-system (RAS), the residual cardiorenal risk of these patients remains substantially ...